Authors


Karla Huntsman, MSN, RN

Latest:

Contributor: How to Fight the Cold and the Flu This Season

With cold and flu season approaching, tips for avoiding the worst of the respiratory viruses are important for facing the coming months, when health experts expect an uptick in flu cases compared with the past 2 years.


Courtney Bragg, MBA

Latest:

Unmet Health Care and Health-Related Social Needs of Laundromat Users

Laundromats offer a promising outreach setting for Medicaid payers because Medicaid enrollees represent a majority of laundromat users and have disproportionately high levels of unmet needs.


Inna Cintina, PhD

Latest:

High-Need Beneficiary Enrollment Patterns in Medicare Advantage and Traditional Medicare

Accounting for 32% of all Medicare enrollees in 2019, high-need beneficiaries were more likely to be in traditional Medicare than Medicare Advantage.


Geoffrey D. Barnes, MD, MSc

Latest:

Diagnosis Patterns and Stress Testing Trends After Implementing High-Sensitivity Troponin Assay

This study found that switching from a conventional troponin assay to a high-sensitivity troponin assay resulted in changes to diagnosis patterns and stress testing trends.


Rajesh Reddy, MD, MPH

Latest:

Congress Ends Surprise Billing: Implications for Payers, Providers, and Patients

The No Surprises Act represents a rare bipartisan moment for Congress and a long-needed safeguard for patients that will reorient relationships among payers and providers.


Paige Wickner, MD

Latest:

At-Home Hemoglobin A1c Testing During COVID-19 Improved Glycemic Control

Providing at-home hemoglobin A1c test kits increases testing rates and facilitates hemoglobin A1c reduction over time among members of a large commercial health plan with diabetes.


Tina Duong, PhD, MPT

Latest:

Final Panel Thoughts on the Management of SMA

Panelists discuss how spinal muscular atrophy (SMA) treatment will evolve over the next 5 years, likely incorporating improved gene therapy delivery systems, combination therapies, and rehabilitation models, while maintaining individualized approaches for each patient.


Lan Xie, MB

Latest:

How Do Primary Community Hospitals Enact Early Response to COVID-19? The Experience From Chengdu, China

Our hospital is a primary hospital in Chengdu, China. Since February 5, our hospital has been listed as the primary designated medical unit for treating new patients with coronavirus disease 2019 (COVID-19) in Jinniu District. In this letter, we share our COVID-19 experience with readers.



Ani Bilazarian, PhD, BSN, RN

Latest:

Primary Care Practice Structural Capabilities in Health Professional Shortage Areas

Nurse practitioners are increasingly meeting primary care demands in underserved areas and are more likely to deliver structural capabilities related to chronic disease management.


Linda Diem Tran, PhD, MPP

Latest:

Cancellations in Primary Care in the Veterans Affairs Health Care System

This article examines the prevalence of unused primary care appointments in the Veterans Affairs Health Care System.


Anjali Gopalan, MD, MS

Latest:

Primary Care Video and Telephone Telemedicine During the COVID-19 Pandemic: Treatment and Follow-up Health Care Utilization

Telephone visits may offer a simple and convenient option to address patient primary care needs without raising safety concerns.


Ling Chen, MD, MPH

Latest:

Cost Sharing for Oral Lenvatinib Among Commercially Insured Patients

Among a cohort of insured patients with cancer, the median total monthly cost of oral lenvatinib was $17,253, and 75% of patients paid $100 or less out of pocket per month for the drug.


Ervant J. Maksabedian Hernandez, PhD, MPhil

Latest:

Association of Physician Specialty With Psoriatic Arthritis Treatment and Costs

In this retrospective cohort study of patients with newly diagnosed psoriatic arthritis, the authors examine the association of treatment selection and costs with physician specialty.


Anne Brisendine, DrPH

Latest:

Social Determinants of Health and Emergency Department Utilization in Alabama Children’s Health Insurance Program

Community social determinants of health such as rurality and low socioeconomic status moderate the association between an individual’s race and emergency care use.


Sean P. Fleming, MSW

Latest:

Patterns of Opioid Use in Commercially Insured Patients With Cancer

Among the fewer than half of patients with cancer who received opioid fills, a relatively small proportion (2.5%) had potentially problematic opioid use.


Adam S. Kittai, MD

Latest:

Future Directions of BTK Inhibitors in Leukemia and Lymphoma

Experts discuss future directions of BTK inhibitors.


Anjana Sharma, MD

Latest:

Implementing Team-Based Telemedicine Workflows in Safety-Net Primary Care

Telemedicine in safety-net primary care faces particular challenges. Consistent, team-based workflows can support video visit implementation and health care maintenance in telemedicine visits.


Ashley Son, MS

Latest:

Contributor: Patient-Centered Approaches to Supporting Medication Adherence Among Persons With Schizophrenia

There are effective strategies that can be employed concurrently to promote adherence to medications for schizophrenia, including but not limited to pharmacological, technological, and psychosocial interventions.


Quinn Everts

Latest:

How Understanding Risk Factors Can Help Patients With Chronic Diseases Quit Smoking

How much does education about the specific risks of smoking assist in smoking cessation?


Natalia Golovashkina, PhD

Latest:

Factors Associated With Unplanned Admissions Among Patients With Chronic Conditions

This study identified risk factors for unplanned admissions among patients with multiple chronic conditions to inform focused interventions.


R. Scott Leslie, PhD, MPH

Latest:

Scenario Analysis When Conducting Budget Impact Analyses for Rare Diseases

The authors propose conducting a scenario analysis for interventions to treat rare diseases by varying health plan size to demonstrate the variability of potential budget impact.


Stephanie G. Witwer, PhD, RN, NEA-BC

Latest:

Impact of Medical Care Coordination Intervention on Patient Activation

This observational evaluation compared an adult medical care coordination intervention with usual care and found that the intervention was associated with significant improvements in patient activation.


Surbhi Sidana, MD, MBBS | Image Credit: © Stanford University
Surbhi Sidana, MD, MBBS

Latest:

Safety Should Always Be a Priority With CAR T for Multiple Myeloma: Surbhi Sidana, MD, MBBS

Cilta-cel’s mechanism of action allows it to penetrate challenging areas of multiple myeloma, providing deep and durable responses even in high-risk patients, explains Surbhi Sidana, MD, MBBS, Stanford University. Still, safety trade-offs should always be a consideration, she adds.


Ann Marie Huffenberger, DBA, RN, NEA-BC

Latest:

Economics of a Health System’s Direct-to-Consumer Telemedicine for Its Employees

A direct-to-consumer telemedicine service resulted in lower per-episode unit costs for care within 7 days and only marginally increased the use of services overall.


Jeffrey Crowley, MPH

Latest:

Future of PrEP

Experts in HIV provide closing thoughts on the future of PrEP, including improvement of uptake and addressing access disparities.


Randi Foraker, PhD, MA

Latest:

Using Electronic Health Records and Claims Data to Identify High-risk Patients Likely to Benefit From Palliative Care

Deep learning algorithms could improve palliative care by predicting mortality from electronic health records and claims data.


Alan Gabot, PharmD

Latest:

Cost-Benefit Analysis of Sacubitril/Valsartan in a Medicaid Population

The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan.


Denise Tran, PharmD

Latest:

Effects of Individualized Nurse-Led Care Plans on Olaparib Treatment Duration

A nurse-led personalized care program conducted through a specialty pharmacy prolonged medication persistence among patients with cancer receiving olaparib.


Emel Sezer, MD

Latest:

Evaluation of Biosimilar Trastuzumab MYL-1401O in HER2-Positive Breast Cancer

The authors evaluate the effect and safety of biosimilar trastuzumab MYL-1401O in human epidermal growth factor receptor 2 (HER2)–positive early-stage (neoadjuvant and adjuvant therapy) and metastatic (palliative therapy) breast cancer using real-world data.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo